Skip to main content
Abpro Bio Co., Ltd. logo

Abpro Bio Co., Ltd. — Investor Relations & Filings

Ticker · 195990 ISIN · KR7195990007 KO Manufacturing
Open in API
Filings indexed 430 across all filing types
Latest filing 2023-09-26 Major Shareholding Noti…
Country KR South Korea
Listing KO 195990

About Abpro Bio Co., Ltd.

https://abpro.co/

Abpro Bio Co., Ltd. is a company engaged in the manufacture and sale of precision machine tools. Its primary products include tapping centers, 2-spindle machining centers, and other specialized industrial machinery. In addition to its core manufacturing operations, the company has diversified its business to include a biotechnology division. This division is involved in the development of next-generation antibody therapeutics, often through exclusive development agreements and collaborations with strategic partners.

Recent filings

Filing Released Lang Actions
[기재정정]최대주주변경을수반하는주식담보제공계약체결
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'Correction Report' (정정신고) for a 'Pledge of Shares Involving a Change in the Largest Shareholder' (최대주주 변경을 수반하는 주식 담보제공 계약 체결). This type of filing relates to financing activities and capital structure changes, specifically the pledging of shares as collateral. It does not fit into the specific categories of M&A, dividends, or director dealings, and is a formal regulatory disclosure of a financial transaction. Therefore, it is classified as a Capital/Financing Update.
2023-09-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and purpose of holding (management influence) by a specific entity (Veritas Investment Association) in a listed company (ABProBio). This type of filing is specifically categorized as a Major Shareholding Notification.
2023-09-26 Korean
조회공시요구(현저한시황변동)
Regulatory Filings Classification · 100% confidence The document is a formal request from a regulatory body (exchange) to the company (ABPROBIO) regarding 'significant market fluctuations' (현저한 시황변동). This is a standard regulatory inquiry requiring a response by a specific deadline. Since it is a regulatory announcement regarding market activity and does not fit into specific categories like earnings or dividends, it falls under the general regulatory filing category.
2023-09-26 Korean
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'Abpro Bio Co., Ltd.' covering the period from January 1, 2023, to June 30, 2023. It contains detailed corporate information, financial data, business descriptions, and management discussions, which are characteristic of an interim financial report. According to the provided definitions, a comprehensive financial report for a period shorter than a full fiscal year is classified as an Interim / Quarterly Report (IR). H1 2023
2023-08-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements (pledges) of a major shareholder (Veritas Investment Fund) in the company ABProBio. This type of filing is specifically categorized as a Major Shareholding Notification (MRQ) in the provided schema.
2023-06-27 Korean
최대주주변경을수반하는주식담보제공계약해제ㆍ취소등
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the cancellation of a stock collateral agreement involving the company's largest shareholder. It details the repayment of loans and the subsequent release of pledged shares. Since this is a specific regulatory disclosure regarding capital structure and share collateralization that does not fit into categories like M&A, dividends, or director dealings, it is classified as a general regulatory filing.
2023-06-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.